Artivion (AORT) Reiterated at Market Outperform by Citizens on AMDS Prosthesis Growth
Tweet Send to a Friend
Citizens analyst Daniel Stauder reiterated a Market Outperform rating and $48.00 price target on Artivion Inc. (NYSE: AORT).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
